Study to clarify the mechanism of developing hyperkalemia due to hypothyroidism in thyroidectomized patients undergoing thyroid hormone withdrawal for radioactive iodine therapy.

Study to clarify the mechanism of developing hyperkalemia due to hypothyroidism in thyroidectomized patients undergoing thyroid hormone withdrawal for radioactive iodine therapy. - Hyperkalemia in hypothyroidism

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000034377

Enrollment

100

Registered

2018-10-04

Start date

2015-02-07

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Thyroid cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Thyroidectomized patients with thyroid cancer who admitted to Nagasaki University Hospital to take radioactive iodine therapy with undergoing thyroid hormone withdrawal.

Exclusion criteria

Exclusion criteria: Patients administered with diuretic drug, ACE inhibitor, ARB, or steroid hormone.

Design outcomes

Primary

Measure	Time frame
Levels of serum potassium, and plasma rennin activity, aldosterone, cortisol, ACTH, ADH.	—

Countries

Japan

Contacts

Public ContactIchiro Horie

Nagasaki University Endocrinology and Metabolism

holy197741@me.com0958197200

Outcome results